Continuous monitoring of the drug's safety and effectiveness in real-world settings is crucial after approval. Any adverse events or unexpected side effects should be reported and investigated.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
methyl 3-(4-((2-chloropyridin-4-yl)ethynyl)phenyl)propanoate
tert-butyl (S)-3-((5-bromo-2-chloropyrimidin-4-yl)amino)piperidine-1-carboxylate
bis(benzonitrile)palladium(II) dichloride
C21H21BrN2O2
methyl 3-{N-(1-butyl)-2-chloro-4-{[3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}benzamido}benzoate
Benzeneacetic acid, a-aMino-4-hydroxy-, ethyl ester, (aR)-
4-methylphenyl 3-[({7-[({7-[({3-[(4-methylphenyl)oxysulfonyl]phenyl}amino)sulfonyl]-2-naphthyl}amino)carbonylamino]-2-naphthyl}sulfonyl)amino]benzenesulfonate
5-Amino-2-chlorobenzoic acid
Pyridine
5-(4-ethoxyphenyl)-1-(2-methoxyphenyl)-3-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)-1H-pyrazole
phosphorus trichloride
N1-(7-chloroquinolin-4-yl)-N2-{2-[(dimethylamino)methyl]benzyl}ethan-1,2-diamine
4,6-DICHLORO-1-METHYL- 1H-PYRAZOLO[3,4-B]PYRIDINE
UREA
